{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:28:11Z","timestamp":1785518891178,"version":"3.56.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"Indiana University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013991","name":"Texas A&M University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajpath.2021.08.011","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T02:38:19Z","timestamp":1631155099000},"page":"2052-2063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-5022","authenticated-orcid":false,"given":"Sukanya","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1478-8241","authenticated-orcid":false,"given":"Priyanka","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-8007","authenticated-orcid":false,"given":"Burcin","family":"Ekser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Bayless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zawieja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-3021","authenticated-orcid":false,"given":"Gianfranco","family":"Alpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon S.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-3198","authenticated-orcid":false,"given":"Sanjukta","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2021.08.011_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fonc.2020.00171","article-title":"Global trends in incidence rates of primary adult liver cancers: a systematic review and meta-analysis","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2006-939841","article-title":"Epidemiology of primary and secondary liver cancers","volume":"23","author":"Ananthakrishnan","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib4","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.23439","article-title":"VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma","volume":"122","author":"Thelen","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2021.08.011_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2011.03.006","article-title":"The global epidemiology of hepatocellular carcinoma: present and future","volume":"15","author":"McGlynn","year":"2011","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ajpath.2021.08.011_bib6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cncr.29692","article-title":"Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma","volume":"122","author":"Esnaola","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2021.08.011_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.ajpath.2021.08.011_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jso.23605","article-title":"Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis","volume":"110","author":"Amini","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijscr.2016.09.044","article-title":"Liver angiosarcoma: rare tumour associated with a poor prognosis, literature review and case report","volume":"28","author":"Millan","year":"2016","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.ajpath.2021.08.011_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ejso.2015.04.022","article-title":"Primary hepatic angiosarcoma","volume":"41","author":"Chaudhary","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2018.12.013","article-title":"CT and MRI studies of hepatic angiosarcoma","volume":"74","author":"Yi","year":"2019","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib12","series-title":"Oxford Textbook of Clinical Hepatology","first-page":"37","article-title":"Hepatic lymph and lymphatics","author":"Barrowman","year":"1991"},{"key":"10.1016\/j.ajpath.2021.08.011_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ar.20681","article-title":"Lymph circulation in the liver","volume":"291","author":"Ohtani","year":"2008","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.ajpath.2021.08.011_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coi.2018.04.028","article-title":"Lymphatics in the liver","volume":"53","author":"Tanaka","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib15","doi-asserted-by":"crossref","first-page":"21808","DOI":"10.1038\/s41598-020-78727-y","article-title":"Liver lymphatic drainage patterns follow segmental anatomy in a murine model","volume":"10","author":"Frenkel","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2021.08.011_bib16","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3389\/fphys.2019.01579","article-title":"Emerging roles for lymphatics in chronic liver disease","volume":"10","author":"Burchill","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00234299","article-title":"The lymphatics of the liver","volume":"190","author":"Trutmann","year":"1994","journal-title":"Anat Embryol (Berl)"},{"key":"10.1016\/j.ajpath.2021.08.011_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jcmgh.2016.09.002","article-title":"The hepatic lymphatic vascular system: structure, function, markers, and lymphangiogenesis","volume":"2","author":"Tanaka","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.28650","article-title":"The lymphatic system: a new frontier in hepatology","volume":"64","author":"Iwakiri","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1679\/aohc.66.317","article-title":"Origins and pathways of fluid entering sublobular lymphatic vessels in cat livers","volume":"66","author":"Poonkhum","year":"2003","journal-title":"Arch Histol Cytol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib21","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s11605-014-2667-1","article-title":"Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review","volume":"18","author":"Amini","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ajpath.2021.08.011_bib22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/TP.0000000000002690","article-title":"Immune cell trafficking to the liver","volume":"103","author":"Chaudhry","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ajpath.2021.08.011_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cld.2012.11.001","article-title":"Systemic causes of cholestasis","volume":"17","author":"Delemos","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ajpath.2021.08.011_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-230X-10-131","article-title":"Lymphatic marker podoplanin\/D2-40 in human advanced cirrhotic liver--re-evaluations of microlymphatic abnormalities","volume":"10","author":"Yokomori","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib25","first-page":"68","article-title":"Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases","volume":"2","author":"Franchitto","year":"2013","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.ajpath.2021.08.011_bib26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib27","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fimmu.2016.00548","article-title":"The role of lymphatic endothelial cells in liver injury and tumor development","volume":"7","author":"Lukacs-Kornek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2008-12-196840","article-title":"Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1","volume":"115","author":"Flister","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2021.08.011_bib30","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1172\/JCI79434","article-title":"Lymphatic vessels regulate immune microenvironments in human and murine melanoma","volume":"126","author":"Lund","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2021.08.011_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1158\/2326-6066.CIR-14-0115","article-title":"Immunomodulatory roles of lymphatic vessels in cancer progression","volume":"2","author":"Swartz","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib32","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s00268-010-0400-0","article-title":"Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma","volume":"34","author":"Xiaohong","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ajpath.2021.08.011_bib33","doi-asserted-by":"crossref","first-page":"e95889","DOI":"10.1371\/journal.pone.0095889","article-title":"Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis","volume":"9","author":"Xia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2021.08.011_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1015-9584(11)60020-1","article-title":"Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome","volume":"34","author":"Lee","year":"2011","journal-title":"Asian J Surg"},{"key":"10.1016\/j.ajpath.2021.08.011_bib35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1148\/radiology.216.3.r00se24698","article-title":"Extrahepatic metastases of hepatocellular carcinoma","volume":"216","author":"Katyal","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib36","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1245\/s10434-009-0380-1","article-title":"Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma","volume":"16","author":"Thelen","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib37","first-page":"8079","article-title":"LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis","volume":"61","author":"Mouta Carreira","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1148\/radiology.203.1.9122379","article-title":"Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients","volume":"203","author":"Dodd","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib39","first-page":"939","article-title":"[Pathology of hepatocellular carcinoma]. Japanese","volume":"84","author":"Nakashima","year":"1983","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"10.1016\/j.ajpath.2021.08.011_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3748\/wjg.v8.i3.385","article-title":"The prognostic molecular markers in hepatocellular carcinoma","volume":"8","author":"Qin","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib41","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1634\/theoncologist.2010-0358","article-title":"Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma","volume":"16","author":"Xiang","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ajpath.2021.08.011_bib42","doi-asserted-by":"crossref","first-page":"1710670","DOI":"10.1155\/2019\/1710670","article-title":"A noninvasive prediction nomogram for lymph node metastasis of hepatocellular carcinoma based on serum long noncoding RNAs","volume":"2019","author":"Ma","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajpath.2021.08.011_bib43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fmed.2019.00293","article-title":"Inflammation and progression of cholangiocarcinoma: role of angiogenic and lymphangiogenic mechanisms","volume":"6","author":"Roy","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajpath.2021.08.011_bib47","first-page":"130","article-title":"Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies","volume":"2","author":"Cadamuro","year":"2013","journal-title":"Transl Gastrointest Cancer"},{"key":"10.1016\/j.ajpath.2021.08.011_bib48","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.25808","article-title":"The prognosis of perihilar cholangiocarcinoma after radical treatments","volume":"56","author":"Fabris","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12885-019-5420-z","article-title":"Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma","volume":"19","author":"Sha","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2021.08.011_bib50","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"Cadamuro","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/1535370220934038","article-title":"Hypoxic tumor microenvironment: implications for cancer therapy","volume":"245","author":"Roy","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.ajpath.2021.08.011_bib52","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.7314\/APJCP.2014.15.14.5873","article-title":"High expression of HIF-1alpha, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis","volume":"15","author":"Thongchot","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ajpath.2021.08.011_bib53","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00535-008-2255-9","article-title":"Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma","volume":"43","author":"Thelen","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib54","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib55","doi-asserted-by":"crossref","first-page":"15593","DOI":"10.1073\/pnas.0507865102","article-title":"Insulin-like growth factors 1 and 2 induce lymphangiogenesis in\u00a0vivo","volume":"102","author":"Bjorndahl","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2021.08.011_bib56","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.ejca.2007.04.024","article-title":"Tumour-derived fibroblast growth factor-2 exerts lymphangiogenic effects through Akt\/mTOR\/p70S6kinase pathway in rat lymphatic endothelial cells","volume":"43","author":"Matsuo","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2021.08.011_bib57","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/sj.jid.5700464","article-title":"New insights into the molecular control of the lymphatic vascular system and its role in disease","volume":"126","author":"Cueni","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/cells8060518","article-title":"Cancer mutations in FGFR2 prevent a negative feedback loop mediated by the ERK1\/2 pathway","volume":"8","author":"Szybowska","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2021.08.011_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajpath.2021.08.011_bib60","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","article-title":"Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1","volume":"3","author":"Gale","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajpath.2021.08.011_bib61","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1182\/blood-2004-08-3327","article-title":"Angiopoietin-1 promotes lymphatic sprouting and hyperplasia","volume":"105","author":"Tammela","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2021.08.011_bib62","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1038\/onc.2011.602","article-title":"Interaction of tumor cells and lymphatic vessels in cancer progression","volume":"31","author":"Alitalo","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2021.08.011_bib63","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1158\/0008-5472.CAN-07-6506","article-title":"A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis","volume":"68","author":"Clasper","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib64","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2008.01.029","article-title":"Blocking neuropilin-2 function inhibits tumor cell metastasis","volume":"13","author":"Caunt","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2021.08.011_bib65","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fimmu.2019.00518","article-title":"The interplay between lymphatic vessels and chemokines","volume":"10","author":"Farnsworth","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib66","doi-asserted-by":"crossref","first-page":"eaal4712","DOI":"10.1126\/scitranslmed.aal4712","article-title":"Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma","volume":"9","author":"Fankhauser","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2021.08.011_bib67","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","article-title":"VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2021.08.011_bib68","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcdb.2015.01.008","article-title":"The lymph node microenvironment and its role in the progression of metastatic cancer","volume":"38","author":"Pereira","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib69","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.4049\/jimmunol.1302492","article-title":"Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells","volume":"192","author":"Hirosue","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib70","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1084\/jem.20180654","article-title":"IFNgamma-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin","volume":"215","author":"Lane","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2021.08.011_bib71","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2021.08.011_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0975-3583.85260","article-title":"An overview of lymphatic vessels and their emerging role in cardiovascular disease","volume":"2","author":"Jones","year":"2011","journal-title":"J Cardiovasc Dis Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib73","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.18632\/oncotarget.4018","article-title":"Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation","volume":"6","author":"Kimura","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2021.08.011_bib74","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00280-016-3134-3","article-title":"Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856\/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer","volume":"78","author":"Saif","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib75","doi-asserted-by":"crossref","first-page":"e68755","DOI":"10.1371\/journal.pone.0068755","article-title":"Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis","volume":"8","author":"Gogineni","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2021.08.011_bib76","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1172\/JCI71606","article-title":"Mechanisms of lymphatic metastasis","volume":"124","author":"Karaman","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2021.08.011_bib77","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2406::AID-CNCR31>3.0.CO;2-E","article-title":"Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors","volume":"86","author":"Partanen","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2021.08.011_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.1343","article-title":"Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer","volume":"200","author":"Williams","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib79","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.celrep.2016.09.083","article-title":"Macrophage-induced lymphangiogenesis and metastasis following paclitaxel chemotherapy is regulated by VEGFR3","volume":"17","author":"Alishekevitz","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2021.08.011_bib80","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.celrep.2019.04.076","article-title":"Integrin-mediated macrophage adhesion promotes lymphovascular dissemination in breast cancer","volume":"27","author":"Evans","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2021.08.011_bib81","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.aal3622","article-title":"Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice","volume":"359","author":"Pereira","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2021.08.011_bib82","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1126\/science.aal3662","article-title":"Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice","volume":"359","author":"Brown","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2021.08.011_bib83","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2021.08.011_bib84","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11523-016-0427-8","article-title":"Learning from 7 years of experience with sorafenib in advanced HCC: sorafenib better than sorafenib?","volume":"11","author":"Faivre","year":"2016","journal-title":"Target Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib85","first-page":"834","article-title":"Effect of sorafenib in a murine high risk penetrating keratoplasty model","volume":"10","author":"Cho","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib86","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1002\/onco.13566","article-title":"FDA supplemental approval summary: lenvatinib for the treatment of unresectable hepatocellular carcinoma","volume":"26","author":"Nair","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ajpath.2021.08.011_bib87","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1158\/1078-0432.CCR-07-5270","article-title":"Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase","volume":"14","author":"Matsui","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2045-824X-6-18","article-title":"Lenvatinib, an angiogenesis inhibitor targeting VEGFR\/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage","volume":"6","author":"Yamamoto","year":"2014","journal-title":"Vasc Cell"},{"key":"10.1016\/j.ajpath.2021.08.011_bib89","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1158\/0008-5472.CAN-04-4576","article-title":"Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels","volume":"65","author":"He","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib90","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jnci\/94.11.819","article-title":"Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling","volume":"94","author":"He","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2021.08.011_bib91","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1078-0432.CCR-09-3368","article-title":"Phase 1 study of AMG 386, a selective angiopoietin 1\/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors","volume":"16","author":"Mita","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib92","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1200\/JCO.2009.23.7537","article-title":"Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2","volume":"28","author":"Spratlin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib93","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/jgo.2020.02.10","article-title":"Application of photodynamic therapy for liver malignancies","volume":"11","author":"Zou","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib94","doi-asserted-by":"crossref","first-page":"69ra11","DOI":"10.1126\/scitranslmed.3001699","article-title":"Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis","volume":"3","author":"Tammela","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2021.08.011_bib95","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10456-013-9365-6","article-title":"Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis","volume":"17","author":"Kilarski","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ajpath.2021.08.011_bib96","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.31653","article-title":"Organoids and spheroids as models for studying cholestatic liver injury and cholangiocarcinoma","volume":"74","author":"Sato","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.08.011_bib97","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/cancers11111677","article-title":"Models for understanding resistance to chemotherapy in liver cancer","volume":"11","author":"Marin","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2021.08.011_bib98","first-page":"4779","article-title":"Transport of amphipathic anions by human multidrug resistance protein 3","volume":"60","author":"Zeng","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2021.08.011_bib99","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1517\/17425255.4.6.721","article-title":"Utilization of membrane vesicle preparations to study drug-ABC transporter interactions","volume":"4","author":"Glavinas","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ajpath.2021.08.011_bib100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2174\/1389450116666150223121508","article-title":"Molecular bases of chemoresistance in cholangiocarcinoma","volume":"18","author":"Marin","year":"2017","journal-title":"Curr Drug Targets"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944021003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944021003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:39:21Z","timestamp":1757695161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944021003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":100,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0002944021003849"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2021.08.011","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2021.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}